The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry can
PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical Devices Directive – 93/42/EEC MDD and subsequent amendments.
Innovation Norway – the State and the county authorities’ instrument for achieving value-creating business development – has allocated pre-project funds to PubGene to investigate how COREMINE Medical can be used to
PubGene has had dialogue with Norwegian health authorities on a possible role for establishing an information channel on the COVID-19 virus, with continuous update on
PubGene’s project proposal ‘Coremine Vitae: Realising the promise of precision medicine for cancer patients and their healthcare providers with biomedical intelligence reporting’ submitted for the European Innovation Council